# OnCo record treat-ctdna (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/treat-ctdna/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "treat-ctdna", "NCT05512364" ;
  schema:name "TREAT ctDNA"@en ;
  schema:alternateName "EORTC-2129-BCG"@en ;
  schema:description "A European trial that gives the tablet elacestrant to women whose blood shows hormone-receptor-positive breast cancer returning before scans do, to see whether it delays spread."@en ;
  schema:url <https://onco.cc/trials/treat-ctdna/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05512364> ;
  onco:status "recruiting" ;
  onco:phase "3" ;
  schema:startDate "2023-12-15" ;
  onco:related <https://onco.cc/trials/trak-er/> ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/> ;
  onco:targets <https://onco.cc/targets/estrogen-receptor/> ;
  onco:drugs <https://onco.cc/drugs/elacestrant/>, <https://onco.cc/drugs/signatera/>, <https://onco.cc/drugs/tamoxifen/>, <https://onco.cc/drugs/letrozole/>, <https://onco.cc/drugs/anastrozole/>, <https://onco.cc/drugs/exemestane/> ;
  onco:companies <https://onco.cc/companies/natera/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/tumour-informed-assay/> .